New weight loss drugs could mean a $25 billion drag on restaurants by 2025, says Mizuho’s Dan Dolev

October 3, 2023

Dan Dolev, Senior Analyst US Technology – Payments, Processors & Business Services at Mizuho Securities, joins ‘The Exchange’ to discuss how new weight loss drugs could decrease revenue for restaurant transaction platform Toast.

Mizuho news from around the globe
Mizuho Global News
Back to top